Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biomedical Chromatography is Scopus-indexed (Q3, CiteScore 3.3), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by John Wiley and Sons Ltd.
Checked against the index lists dated .
ISSN 0269-3879Verify ISSN ↗1099-0801Verify ISSN ↗
Publisher: John Wiley and Sons Ltd
Cost to publish: About US$3,710 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology | 204 / 328 | 37th | Q3 |
| Clinical Biochemistry | 78 / 124 | 37th | Q3 |
| Analytical Chemistry | 105 / 160 | 34th | Q3 |
| Drug Discovery | 107 / 161 | 33rd | Q3 |
| Biochemistry | 303 / 448 | 32nd | Q3 |
| Molecular Biology | 305 / 414 | 26th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1989–present (also 1986–1987), best quartile Q3, CiteScore 3.3.
Biomedical Chromatography is Q3 in Pharmacology (rank 204 of 328), Q3 in Clinical Biochemistry (rank 78 of 124) and Q3 in Analytical Chemistry (rank 105 of 160), by CiteScore 2025. It is ranked in 6 subject areas in all.
Biomedical Chromatography is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.3, which places it in quartile Q3 at the 37th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.368, quartile Q3, with an H-index of 76.
The publisher lists an article processing charge of about US$3,710 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Biomedical Chromatography is published by John Wiley and Sons Ltd. Its print ISSN is 0269-3879 and its online ISSN is 1099-0801.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Biomedical Chromatography has an h-index of 80 and a 2-year mean of 1.64 citations per paper (OpenAlex). Its Scopus CiteScore is 3.3, quartile Q3. On 2-year citations it ranks #195 of 319 Scopus journals in Pharmacology.
Biomedical Chromatography published 379 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from China (56.1%), India (22.8%) and United States (4.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 6 retracted papers are recorded (0.8 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.